Cargando…

Changes in Plasma Levels of Natural Anticoagulants in Disseminated Intravascular Coagulation: High Prognostic Value of Antithrombin and Protein C in Patients with Underlying Sepsis or Severe Infection

BACKGROUND: Dysfunctional natural anticoagulant systems enhance intravascular fibrin for mation in disseminated intravascular coagulation (DIC), and plasma levels of natural anti coagulants can be used in the diagnosis and prognosis of DIC. Herein, the diagnostic value of 4 natural anticoagulants wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Qute, Hong, Ki Ho, Kim, Ji-Eun, Kim, Hyun Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948838/ https://www.ncbi.nlm.nih.gov/pubmed/24624342 http://dx.doi.org/10.3343/alm.2014.34.2.85

Ejemplares similares

Antithrombin III concentrate may contribute to sepsis in nonovert disseminated intravascular coagulation
por: Saito, Noriko, et al.
Publicado: (2013)

Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2014)

Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation
por: Nagafuchi, Hiroyuki, et al.
Publicado: (2019)

Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure
por: Kuroda, Hiromitsu, et al.
Publicado: (2020)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2017)

Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation
por: Morita, Nozomi, et al.
Publicado: (2018)

Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Akahoshi, Tomohiko, et al.
Publicado: (2022)

Is antithrombin treatment of disseminated intravascular coagulation a quixotic goal?
por: Seam, Nitin, et al.
Publicado: (2014)

A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis
por: Gando, Satoshi, et al.
Publicado: (2013)

Anticoagulant therapies against sepsis‐induced disseminated intravascular coagulation
por: Umemura, Yutaka, et al.
Publicado: (2023)

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017)

Association of antithrombin with development of trauma-induced disseminated intravascular coagulation and outcomes
por: Wada, Takeshi, et al.
Publicado: (2022)

Relationship between protein C and antithrombin III deficiencies in sepsis without disseminated intravascular coagulation status
por: Takeda, Munekazu, et al.
Publicado: (2008)

Comparison of Antithrombin III and Pentoxifylline Treatments in Gram Negative Sepsis Patients Developing Disseminated Intravascular Coagulation
por: Ozden, Mesure Gul Nihan, et al.
Publicado: (2019)

Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Murao, Atsushi, et al.
Publicado: (2022)

Sepsis and disseminated intravascular coagulation
por: Okamoto, Kohji, et al.
Publicado: (2016)

Effect of Antithrombin III Administration on the Prognosis of Severe Trauma Patients with Disseminated Intravascular Coagulation
por: Chung, Jae Sik, et al.
Publicado: (2023)

Bleeding complications of anticoagulant therapy in sepsis-induced disseminated intravascular coagulation
por: Iba, Toshiaki
Publicado: (2016)

Effect of High-dose Antithrombin Supplementation in Patients with Septic Shock and Disseminated Intravascular Coagulation
por: Kim, Youn-Jung, et al.
Publicado: (2019)

Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study
por: Hayakawa, Mineji, et al.
Publicado: (2018)

Use of Antithrombin and Thrombomodulin in the Management of Disseminated Intravascular Coagulation in Patients with Acute Cholangitis
por: Nakahara, Kazunari, et al.
Publicado: (2013)

Effects of Antithrombin on Persistent Inflammation, Immunosuppression, and Catabolism Syndrome among Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Kanda, Naoki, et al.
Publicado: (2023)

Optimal Timing and Early Intervention With Anticoagulant Therapy for Sepsis-Induced Disseminated Intravascular Coagulation
por: Yamakawa, Kazuma, et al.
Publicado: (2019)

Age Is Associated With the Efficacy of Anticoagulant Therapies Against Sepsis-Induced Disseminated Intravascular Coagulation
por: Takahashi, Kyosuke, et al.
Publicado: (2021)

Use of antithrombin III in cancer patients with sepsis complicated with disseminated intravascular coagulopathy
por: Polansky, M, et al.
Publicado: (1998)

Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study
por: Umemura, Yutaka, et al.
Publicado: (2018)

Disseminated Intravascular Coagulation in Sepsis and Associated Factors
por: Rinaldi, Ikhwan, et al.
Publicado: (2022)

Studies on Therapeutic Effects and Pathological Features of an Antithrombin Preparation in Septic Disseminated Intravascular Coagulation Patients
por: Sakamoto, Yuichiro, et al.
Publicado: (2013)

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey
por: Iba, Toshiaki, et al.
Publicado: (2014)

An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome
por: Endo, Shigeatsu, et al.
Publicado: (2018)

Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated Coagulopathy
por: Wiedermann, Christian J.
Publicado: (2022)

The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2023)

Sepsis-Associated Disseminated Intravascular Coagulation and Thromboembolic Disease
por: Semeraro, Nicola, et al.
Publicado: (2010)

Markers of Inflammation and Infection in Sepsis and Disseminated Intravascular Coagulation
por: Patel, Priya, et al.
Publicado: (2019)

Diagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2019)

Disseminated intravascular coagulation
por: Venugopal, A
Publicado: (2014)

Effectiveness of combined antithrombin and thrombomodulin therapy on in-hospital mortality in mechanically ventilated septic patients with disseminated intravascular coagulation
por: Umegaki, Takeshi, et al.
Publicado: (2020)

Plasma Factor XIII Activity in Patients with Disseminated Intravascular Coagulation
por: Song, Jae Woo, et al.
Publicado: (2006)

Hemodialysis without Anticoagulation for a Patient with Chronic Disseminated Intravascular Coagulation
por: Yamanouchi, Masayuki, et al.
Publicado: (2014)

Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation
por: Hwang, Sang Mee, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g9n7tfh3g2ff9oj1vso1uf5enk